Is AURA or BCAB more undervalued in 2026?

CirclFi compares Aura Biosciences, Inc. (AURA) and BioAtla, Inc. (BCAB) using 13 institutional-grade valuation models. AURA has a Quality of Company score of 5.2/10 while BCAB scores 3.4/10.

Which is a better buy — AURA or BCAB?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do AURA and BCAB valuations compare?

AURA at $7.47 and BCAB at $3.93 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

AURA vs BCAB Valuation Comparison 2026 — Intrinsic Value Analysis

AURA

Biological Products, (No Diagnostic Substances)

Aura Biosciences, Inc.

Quality

5.2

out of 10

Value Trap

SAFE

Price

$7.47

Last close

Models

9/13

Active

BCAB

Biological Products, (No Diagnostic Substances)

BioAtla, Inc.

Quality

3.4

out of 10

Value Trap

LOW

Price

$3.93

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	AURA Fair Value	AURA Upside	BCAB Fair Value	BCAB Upside
Bayesian DCF	Intrinsic	$2.43	-67.4%	$1.60	-59.2%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.59	-92.1%	$0.19	-95.5%
Dynamic NAV	Asset-Based	$1.80	-75.9%	$22.05	+461.0%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for AURA vs BCAB — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

AURA vs BCAB — Which Stock Is More Undervalued?

AURA scores higher with a 5.2/10 quality rating vs BCAB's 3.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Aura Biosciences, Inc. (AURA) and BioAtla, Inc. (BCAB) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

AURA currently trades at $7.47 with a QOC of 5.2/10, while BCAB trades at $3.93 with a QOC of 3.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).